RxDoctor Payments Data

Vivian Wanjohi

Nurse Practitioner · New Haven, CTNPI 1851039200

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,940 of the $5,252 with a category attached, or 75.0%. It is spread thinly across 44 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,670 and has fallen 54.2% since, to $1,221 in 2025. Among nurse practitioner clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,252in general payments, 2019–2025

Across 202 payments — averaging $26.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Seagen Inc.$599
  • Johnson & Johnson$504
  • Incyte Corporation$394
  • Pfizer$356
  • Bristol Myers Squibb$346
  • Sobi, Inc$266
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$3,94075%
  • Education$1,31225%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,252 in reported general payments places this provider in the 95th percentile of 1,162 nurse practitioner providers in Connecticut.

See all nurse practitioner providers in Connecticut

Medicare billing

Part B allowed, 2024
$50,882
Medicare patients
110
Services billed
1,280

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone12$498
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$133

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →